uniQure Announces Update on U.S. Phase I/II Clinical Trial o

uniQure Announces Update on U.S. Phase I/II Clinical Trial of AMT-130 Gene Therapy for the Treatment of Huntington's Disease

uniQure Announces Update on U.S. Phase I/II Clinical Trial of AMT-130 Gene Therapy for the Treatment of Huntington's Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Amsterdam , Noord Holland , Netherlands , Chiara Russodirect , Sarah Tabrizi , Mariae Cantordirect , Ricardo Dolmetsch , Tom Malonedirect , Huntington Disease Center , Cure Huntington Disease Initiative , Phasei Ii Clinical Program , Squre Inc , University College London , Securities Exchange , Neurofilament Light Chain , Total Motor Score , Total Functional Capacity , Unified Huntington , Disease Rating Scale , Disease Center , Data Safety Monitoring Board , Cure Huntington , Disease Initiative , Diagnostic Classification Level , Disease Rating , Motor Score , Functional Capacity , Total Motor , Plight Chain , Cerebrospinal Fluid , Conference Call , Qure Forward Looking , Securities Act , Securities Exchange Act , Annual Report , Quarterly Report , Qure Contacts ,